Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:

Wang, T(2022). The CSiN score and the other neoantigen-based metrics used for comparison. Bio-protocol Preprint. bio-protocol.org/prep1610.
Lu, T., Wang, S., Xu, L., Zhou, Q., Singla, N., Gao, J., Manna, S., Pop, L., Xie, Z., Chen, M., Luke, J. J., Brugarolas, J., Hannan, R. and Wang, T.(2020). Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes . Science Immunology 5(44). DOI: 10.1126/sciimmunol.aaz3199